ZimVie Inc. (ZIMV): Company Short-Term Debts

Public company logo of ZimVie Corp (ZIMV)

The market trend for ZimVie Inc. (ZIMV) shares reflects debt dynamics, where the indicator stands at 0.00. The firm's competitiveness is driven by exclusive patents and strict FDA oversight. Revenues are based on scheduled procedures, although inflation occasionally dampens demand. The business is currently stabilizing through asset optimization and the updating of its dental solutions product line, which remains in high demand in the market.

ZIMV (ZimVie) Company Short-Term Debts history from 04/28/2023 to 11/01/2025

Analytical breakdowns for ZimVie Corp (ZIMV)

- stock price and consensus target price:
Stock Price ZimVie|ZIMV - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization ZimVie Inc.|ZIMV - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share ZimVie|ZIMV - Book Capitalization|Market Value to Book Value Ratio zimvie.com|ZIMV - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio ZimVie Inc.|ZIMV - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital ZimVie Inc.|ZIMV - Company Total Debt Obligations|Debt to Book Capitalization Ratio ZimVie Inc.|ZIMV - Company Long-Term Indebtedness|Company Short-Term Debt ZimVie|Quick Liquidity Indicator zimvie.com
- net income and valuation multiples indicators:
ZIMV - Profit After Payment of Taxes
Fundamental company analysis:ZIMV - ZimVie
Flagship merchandise of ZimVie Corp

The stability of ZimVie Inc. (ZIMV) is determined by the efficiency of working capital management in the production of implants and surgical instruments. This indicator captures the volume of liabilities maturing within one year, reflecting the business's current debt load. Investors should compare debt dynamics with asset growth to assess financial stability. A decrease in this metric may signify either cost optimization or hidden liquidity risks. By analyzing the history of short-term loans and borrowings, one can evaluate the company's actual solvency.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ANGO|Company Short-Term Debt Cerus CERS|Company Short-Term Loans and Borrowings TKNO|MGRM: Company Current Liabilities|STSS - Company Short-Term Debts|infusystem.com (INFU) - Company Short-Term Debt|Company Current Liabilities utahmed.com|KRMD (KORU Medical Systems, Inc.) - Company Short-Term Debts|Short-Term Debt Nyxoah SA NYXH|Company Short-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Short-Term Indebtedness|Zentek Ltd. - Company Current Liabilities|Amount of Current Liabilities ELUT (elutia.com)|MLSS - Company Short-Term Debt|Short-Term Debt Volume NEXGEL Inc. NXGL|RVP (retractable.com) - Company Current Liabilities|Current Liabilities HBIO (Harvard Bioscience Inc.)|FEMY (Femasys Inc.) - Company Short-Term Debts|Meihua Medical (MHUA) - Short-Term Debt Volume|Company Short-Term Debt Predictive Oncology (POAI)|Company Current Liabilities callanjmb.com CJMB|Atrion Corp - Company Current Liabilities|NeuroMetrix Corporation - Company Short-Term Debt